D-0769-2026 Class I Ongoing
FDA drug recall D-0769-2026 was initiated by Buy-Herbal on Mar 21, 2026 and is designated Class I. Reason for recall: Marketed Without an Approved NDA/ANDA: Product contains undeclared drug ingredients dexamethasone and cyproheptadine. The recall status is ongoing. Affected quantity: 71 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Aug 19, 2026
- Initiation Date
- Mar 21, 2026
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 71 bottles
Product description
Kian Pee Wan Capsules, 30-count bottles
Reason for recall
Marketed Without an Approved NDA/ANDA: Product contains undeclared drug ingredients dexamethasone and cyproheptadine.
Distribution pattern
Product was sold to individual consumers via ebay third party seller.
Code information
All lots within expiry.
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0769-2026
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026